Highlights in Crohn’s Disease and Ulcerative Colitis

William J. Sandborn, MD

Special Reporting on:
• Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active UC: PURSUIT-SC
• The Future of IBD Therapy: Individualized and Optimized Therapy and Novel Mechanisms
• Infliximab Concentration and Clinical Outcome in Patients with UC
• Vedolizumab Induction Therapy for UC: Results of GEMINI I, A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase III Trial
• Novel Infliximab and Antibody-to-Infliximab Assays Are Predictive of Disease Activity in Patients with CD
• Accelerated Step-Care Therapy with Early Azathioprine Versus Conventional Step-Care Therapy in CD
• PIANO: A 1,000-Patient Prospective Registry of Pregnancy Outcomes in Women with IBD Exposed to Immunomodulators and Biologic Therapy